Sweet Boron: Boron-Containing Sugar Derivatives as Potential Agents for Boron Neutron Capture Therapy

被引:24
作者
Imperio, Daniela [1 ]
Panza, Luigi [1 ]
机构
[1] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Lgo Donegani 2, I-28100 Novara, Italy
来源
SYMMETRY-BASEL | 2022年 / 14卷 / 02期
关键词
BNCT; boronated sugars; synthesis; biological evaluation; ORTHO-CARBORANYL GLYCOSIDES; IN-VITRO EVALUATION; PHENYLBORONIC ACID; BRAIN-TUMOR; CANCER; BNCT; BORONOPHENYLALANINE; CHEMISTRY; GLUCOSE; LACTOSE;
D O I
10.3390/sym14020182
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Boron neutron capture therapy (BNCT) is a binary type of radiotherapy for the treatment of cancer. Due to recent developments of neutron accelerators and their installation in some hospitals, BNCT is on the rise worldwide and is expected to have a significant impact on patient treatments. Therefore, there is an increasing need for improved boron delivery agents. Among the many small molecules and delivery systems developed, a significant amount of recent research focused on the synthesis of boron-containing sugar and amino acid derivatives to exploit specific transport proteins, as d-glucose transporter 1 (GLUT1) and large neutral amino acid transporter (LAT1), overexpressed by tumor cells. This review will discuss the last year's achievements in the synthesis and some biological evaluation of boronated sugars derivatives. The compounds described in this review are intrinsically asymmetric due to the presence of chiral sugar moieties, often joined to boron clusters, which are structural elements with high symmetry.
引用
收藏
页数:18
相关论文
共 69 条
[1]  
ASBURY AK, 1972, J NEUROPATH EXP NEUR, V3, P278
[2]   High-Affinity Binding of Metallacarborane Cobalt Bis(dicarbollide) Anions to Cyclodextrins and Application to Membrane Translocation [J].
Assaf, Khaleel I. ;
Begaj, Barbara ;
Frank, Angelina ;
Nilam, Mohamed ;
Mougharbel, Ali S. ;
Kortz, Ulrich ;
Nekvinda, Jan ;
Gruner, Bohumir ;
Gabel, Detlef ;
Nau, Werner M. .
JOURNAL OF ORGANIC CHEMISTRY, 2019, 84 (18) :11790-11798
[3]   Boron delivery agents for neutron capture therapy of cancer [J].
Barth, Rolf F. ;
Mi, Peng ;
Yang, Weilian .
CANCER COMMUNICATIONS, 2018, 38 :1-15
[4]   A realistic appraisal of boron neutron capture therapy as a cancer treatment modality [J].
Barth, Rolf F. ;
Zhang, Zizhu ;
Liu, Tong .
CANCER COMMUNICATIONS, 2018, 38
[5]   Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer [J].
Barth, Rolf F. ;
Vicente, M. Graca H. ;
Harling, Otto K. ;
Kiger, W. S., III ;
Riley, Kent J. ;
Binns, Peter J. ;
Wagner, Franz M. ;
Suzuki, Minoru ;
Aihara, Teruhito ;
Kato, Itsuro ;
Kawabata, Shinji .
RADIATION ONCOLOGY, 2012, 7
[6]  
Cross GG, 1998, SYNLETT, P487
[7]   Cobalt bis(dicarbollide) anion and its derivatives [J].
Dash, Barada P. ;
Satapathy, Rashmirekha ;
Swain, Biswa R. ;
Mahanta, Chandra S. ;
Jena, Bibhuti B. ;
Hosmane, Narayan S. .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2017, 849-850 :170-194
[8]   Evidences of strong C-H•••O bond in an o-carboranyl β-lactoside in solution [J].
Donati, A ;
Ristori, S ;
Bonechi, C ;
Panza, L ;
Martini, G ;
Rossi, C .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (30) :8778-8779
[9]   Boron neutron capture therapy: Current status and future perspectives [J].
Dymova, Mayya Alexandrovna ;
Taskaev, Sergey Yurjevich ;
Richter, Vladimir Alexandrovich ;
Kuligina, Elena Vladimirovna .
CANCER COMMUNICATIONS, 2020, 40 (09) :406-421
[10]   PHYSICS AND PHYSIOLOGY OF NEUTRON-CAPTURE THERAPY [J].
FARR, LE ;
ROBERTSON, JS ;
STICKLEY, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1954, 40 (11) :1087-1093